362 related articles for article (PubMed ID: 10330384)
1. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
[TBL] [Abstract][Full Text] [Related]
3. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
4. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.
Lubenow N; Hinz P; Thomaschewski S; Lietz T; Vogler M; Ladwig A; Jünger M; Nauck M; Schellong S; Wander K; Engel G; Ekkernkamp A; Greinacher A
Blood; 2010 Mar; 115(9):1797-803. PubMed ID: 19965682
[TBL] [Abstract][Full Text] [Related]
5. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
6. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
[TBL] [Abstract][Full Text] [Related]
7. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
8. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
10. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
Visentin GP; Malik M; Cyganiak KA; Aster RH
J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
12. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.
Gruel Y; Pouplard C; Nguyen P; Borg JY; Derlon A; Juhan-Vague I; Regnault V; Samama M;
Br J Haematol; 2003 Jun; 121(5):786-92. PubMed ID: 12780795
[TBL] [Abstract][Full Text] [Related]
14. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery.
Trossaërt M; Gaillard A; Commin PL; Amiral J; Vissac AM; Fressinaud E
Br J Haematol; 1998 Jun; 101(4):653-5. PubMed ID: 9674736
[TBL] [Abstract][Full Text] [Related]
15. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
[TBL] [Abstract][Full Text] [Related]
16. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
18. A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test.
Elalamy I; Potevin F; Lecrubier C; Bara L; Marie JP; Samama MM
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):665-71. PubMed ID: 8958387
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
20. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
Amiral J
Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]